SCHEMBL30980751

SCHEMBL30980751

CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1CCCOCCOCCNC(=O)CCOCC(N)(COCCC(=O)NCCOCCOCCC[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O)COCCC(=O)NCCOCCOCCC[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MDK P21741 4/20 0.44
▸ MAPK1 P28482 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ LGALS3 P17931 2/20 0.35
▸ OGA O60502 1/20 0.34
▸ CD69 Q07108 2/20 0.34
▸ ESR1 P03372 1/20 0.33
▸ PGR P06401 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ AR P10275 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ TBXA2R P21731 1/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ LGALS8 O00214 1/20 0.33
▸ LGALS4 P56470 1/20 0.33
▸ CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30980516 0.96 MDK (0.45) MDKMAPK1ALDH1A1THRBLGALS3
SCHEMBL30980494 0.91 MDK (0.41) MDKMAPK1ALDH1A1THRBLGALS3
SCHEMBL15867554 0.87 MAPK1 (0.49) MDKMAPK1ALDH1A1THRBLGALS3
SCHEMBL30980578 0.87 MDK (0.41) MDKMAPK1ALDH1A1THRBLGALS3
SCHEMBL30980522 0.86 MAPK1 (0.43) MDKMAPK1ALDH1A1THRBLGALS3
SCHEMBL16359449 0.86 MAPK1 (0.52) MDKMAPK1ALDH1A1THRBLGALS3
SCHEMBL30980709 0.83 MAPK1 (0.41) MDKMAPK1ALDH1A1THRBLGALS3
SCHEMBL30980649 0.82 MAPK1 (0.43) MDKMAPK1ALDH1A1THRBLGALS3
SCHEMBL16359392 0.81 MAPK1 (0.46) MDKMAPK1ALDH1A1THRBLGALS3
SCHEMBL30980642 0.81 MAPK1 (0.43) MDKMAPK1ALDH1A1THRBLGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651901-A1 CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
WO-2025035040-A1 LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF MUSCLE-SPECIFIC KINASE AUTOANTIBODIES LYCIA THERAPEUTICS, INC. (US) 2025-02-13 — — WO disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
Send feedback